Sept 29 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS AND AIPHARMA ANNOUNCE STRATEGIC
ALLIANCE AND
EQUITY TRANSACTION
* APPILI THERAPEUTICS INC - STRATEGIC ALLIANCE FOR GLOBAL
DEVELOPMENT OF ORAL ANTIVIRAL MEDICINE AVIGAN/REEQONUS
* APPILI - AIPHARMA WILL RECEIVE NUMBER OF CLASS A COMMON
SHARES
OF APPILI AS IS EQUAL TO 24% OF ISSUED AND OUTSTANDING APPILI
SHARES PRIOR TO AGREEMENT
* APPILI THERAPEUTICS INC - EXPECTED THAT AIPHARMA WILL HOLD
ABOUT
19.4% OF ISSUED AND OUTSTANDING APPILI SHARES IMMEDIATELY
FOLLOWING CLOSING
* APPILI THERAPEUTICS INC - IN EXCHANGE, WILL RECEIVE ABOUT
6% OF
ISSUED AND OUTSTANDING AIPHARMA SHARES
Source text for Eikon: ID:nBw47HwvVa
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))